PHVS

Pharvaris BV is a clinical-stage biopharmaceutical company based in Leiden, the Netherlands, dedicated to developing innovative therapies for rare diseases, with a primary focus on hereditary angioedema. Leveraging its proprietary drug development platform, Pharvaris is committed to addressing unmet medical needs and advancing its therapeutic pipeline to improve patient outcomes. By strategically positioning itself in the biopharmaceutical landscape, the company aims to significantly enhance the quality of life for patients suffering from this orphan disease, making it a notable entity in the pursuit of effective treatments for rare conditions.